Susquehanna International Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-67,200
| Closed | -$1.82M | – | 13323 |
|
|
2024
Q2 | $1.82M | Sell |
67,200
-128,000
| -66% | -$2.66M | ﹤0.01% | 5284 |
|
|
2024
Q1 | $3.58M | Buy |
195,200
+98,400
| +102% | +$1.56M | ﹤0.01% | 4184 |
|
|
2023
Q4 | $1.19M | Buy |
96,800
+37,600
| +64% | +$353K | ﹤0.01% | 6567 |
|
|
2023
Q3 | $887K | Buy |
59,200
+52,100
| +734% | +$1.08M | ﹤0.01% | 6894 |
|
|
2023
Q2 | $231K | Buy |
7,100
+200
| +3% | +$7.3K | ﹤0.01% | 9987 |
|
|
2023
Q1 | $270K | Sell |
6,900
-21,100
| -75% | -$1.03M | ﹤0.01% | 9953 |
|
|
2022
Q4 | $1.48M | Sell |
28,000
-22,500
| -45% | -$1.1M | ﹤0.01% | 5323 |
|
|
2022
Q3 | $2.27M | Buy |
+50,500
| New | +$2.17M | ﹤0.01% | 4659 |
|
|
2022
Q1 | – | Sell |
-36,300
| Closed | -$1.55M | – | 14195 |
|
|
2021
Q4 | $1.55M | Buy |
36,300
+11,100
| +44% | +$555K | ﹤0.01% | 6140 |
|
|
2021
Q3 | $1.39M | Sell |
25,200
-9,100
| -27% | -$476K | ﹤0.01% | 6689 |
|
|
2021
Q2 | $1.64M | Sell |
34,300
-28,200
| -45% | -$1.44M | ﹤0.01% | 6398 |
|
|
2021
Q1 | $3.17M | Sell |
62,500
-39,600
| -39% | -$2.2M | ﹤0.01% | 4837 |
|
|
2020
Q4 | $6.43M | Buy |
102,100
+47,400
| +87% | +$2.94M | ﹤0.01% | 3046 |
|
|
2020
Q3 | $3.68M | Buy |
54,700
+12,400
| +29% | +$677K | ﹤0.01% | 3531 |
|
|
2020
Q2 | $1.77M | Buy |
42,300
+30,600
| +262% | +$1.17M | ﹤0.01% | 4719 |
|
|
2020
Q1 | $368K | Buy |
11,700
+1,800
| +18% | +$72.1K | ﹤0.01% | 7578 |
|
|
2019
Q4 | $400K | Buy |
+9,900
| New | +$347K | ﹤0.01% | 7427 |
|
Other funds holding SILK
Susquehanna International Group's SILK Position: Q2 2024 in Review
Susquehanna International Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 32,690 shares — an estimated $680K sold.
Susquehanna International Group first reported a position in SILK in Q4 2019 and held it in 13 quarters. The position peaked at $3.35M in Q2 2023. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.
- Susquehanna International Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Susquehanna International Group sold 32,690 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $680K.
- Susquehanna International Group first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
- Susquehanna International Group's Silk Road Medical, Inc. Common Stock position peaked at $3.35M in Q2 2023.
- 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.